Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.
- DOI
- 10.1038/s41440-026-02756-9
- Published
- 2026 Aug 13
- Container
- Hypertension research : official journal of the Japanese Society of Hypertension
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41440-026-02756-9,
title = {Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.},
author = {Kuwabara M and Hamano T and Ae R},
year = {2026},
journal = {Hypertension research : official journal of the Japanese Society of Hypertension},
doi = {10.1038/s41440-026-02756-9},
url = {https://doi.org/10.1038/s41440-026-02756-9}
}RIS
TY - JOUR TI - Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control. AU - Kuwabara M AU - Hamano T AU - Ae R PY - 2026 JO - Hypertension research : official journal of the Japanese Society of Hypertension DO - 10.1038/s41440-026-02756-9 UR - https://doi.org/10.1038/s41440-026-02756-9 ER -
APA
M, K., T, H., & R, A. (2026). Losartan, uric acid, and cardiometabolic disease: beyond blood pressure control.. Hypertension research : official journal of the Japanese Society of Hypertension. https://doi.org/10.1038/s41440-026-02756-9
Source records
- pubmed · retrieved 2026-09-26T16:27:29.750Z